All News

A phase 3 trial evaluated nivolumab in combination with ipilimumab in patients with previously untreated MPM and successfully met its primary endpoint of overall survival.

Purdue University researchers have created technology that uses optical imaging to better help surgeons map out tumors in the body and understand how certain diseases affect activity in the brain.

Pharmacy Times® invites you to join us and experts in pharmacy to gain insight into the value pharmacists provide in treating patients throughout the pandemic.

Over the past 20 years, the specialty pharmacy channel has been the fastest growing segment of pharmacy practice.

More than 53% of survey respondents reported having a diversion event within the last year, in addition to 37% who were aware of at least 1 colleague who has diverted controlled substances.

Oncology/Hematology pharmacists from Boston Medical Center discuss how COVID-19 has affected their patients.

Today, we’re thanking Angela Garcia, PharmD, MPH, CPh, for her work as an American Pharmacists Association–Academy of Student Pharmacists (APhA-ASP) chapter advisor.

An overview of the most recent legal developments related to COVID-19 that are relevant to pharmacies.

This cohort included 307 patients with schizophrenia and 364 healthy controls who were 45 years old and younger.

Widely used medications for patients with HIV/AIDS may be potential treatments for the coronavirus disease 2019 should the drugs demonstrate safety and efficacy in clinical trials.

Researchers from the Mayo Clinic have found that inappropriate use of high-potency opioids has contributed to the opioid epidemic in the United States.

The National Healthcareer Association believes our community is stronger when we connect to share ideas, tips and resources.

A protein secreted by fat cells may link obesity and breast cancer, according to a newly published article inTrends in Molecular Medicine.

A new study revealed that researchers have found a genetic test that could help doctors determine which patients with multiple myeloma are at “ultra high risk” of their cancer progressing aggressively in its early stages.

Why is this patient on oxybutynin if he does not have any problems with his bladder?

Individuals with type 2 diabetes (T2D) who also experience coronary artery disease (CAD) may need to be treated more aggressively than those with coronary artery disease who do not have diabetes.

The Vantage Label Printer provides reliable, simplified solutions for any pharmacy.

Patients should be selected for therapy based on the FDA approved companion diagnostic for a trastuzumab product.

The FDA has granted accelerated approval to pemigatinib (Pemazyre, Incyte Corporation) as the first treatment for adults with certain types of previously treated, advanced cholangiocarcinoma.

This approval is a part of the first Project Orbis partnership between the FDA, Health Sciences Authority, and Swissmedic.

The FDA granted Amneal Pharmaceuticals for a generic version of buprenorphine (Butrans) transdermal system as well as a Competitive Generic Therapy designation.

Many health care companies are taking the opportunity to deliver testing kits to local pharmacies to properly equip pharmacists with the right resources during the pandemic.

Today we’re celebrating Monique Sanders, RPh, for her work at Script Source Pharmacy in Pearland, Texas.

A new study found that alternative swab materials and commonly available saline are effective for COVID-19 testing, allowing patients to self-administer tests.

New research has found that hospitalized patients with COVID-19, diabetes, and/or uncontrolled hyperglycemia have significantly higher mortality rates.

The study involved measuring the levels and analyzing the expression patterns of more than 3000 proteins in a large number of brain and cerebrospinal fluid samples collected at multiple research centers across the United States.

Loss of smell and taste has been anecdotally linked to COVID-19 infections, according to a study that reported the first empirical findings that strongly associate sensory loss with coronavirus disease 2019.

Researchers have found that approximately 1% of children have an allergy to cow’s milk, but up to 14% of families believe their children may have the condition, pointing to official guidelines for detecting cow’s milk allergy as a possible cause for the overdiagnosis.